By Nicholas G. Miller
Milestone Pharmaceuticals shares fell after the company reported first-quarter results that missed analysts' expectations.
Shares fell 11% to $1.70 in Wednesday's premarket trading.
The company posted a loss of $26.1 million, or 20 cents a share. Analysts polled by FactSet expected a profit of 19 cents a share.
Milestone reported quarterly revenue of $238,000. Wall Street was expecting $30.1 million.
Write to Nicholas G. Miller at nicholas.miller@wsj.com.
(END) Dow Jones Newswires
May 13, 2026 09:08 ET (13:08 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.